BRPI0418722A - nucleic acid-based assays for identification of fc receptor polymorphisms - Google Patents

nucleic acid-based assays for identification of fc receptor polymorphisms

Info

Publication number
BRPI0418722A
BRPI0418722A BRPI0418722-9A BRPI0418722A BRPI0418722A BR PI0418722 A BRPI0418722 A BR PI0418722A BR PI0418722 A BRPI0418722 A BR PI0418722A BR PI0418722 A BRPI0418722 A BR PI0418722A
Authority
BR
Brazil
Prior art keywords
nucleic acid
identification
based assays
receptor polymorphisms
polymorphisms
Prior art date
Application number
BRPI0418722-9A
Other languages
Portuguese (pt)
Inventor
Pablo G Garcia
Susan E Wilson
Gene Guozhong Zhang
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of BRPI0418722A publication Critical patent/BRPI0418722A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

ENSAIOS BASEADOS EM áCIDOS NUCLéICOS PARA IDENTIFICAçãO DE POLIMORFISMOS DO RECEPTOR FC São revelados oligonucleotídeos específicos para polimorfismos de FcyRIII. Também são revelados ensaios de genotipagem baseados em ácido nucléico usando os oligonucleotídeos aqui descritos como iniciadores de amplificação e/ou seqüenciamento.NUCLEIC ACID-BASED TESTS FOR IDENTIFYING FC RECEPTOR POLYMORPHISMS Specific oligonucleotides for FcyRIII polymorphisms are disclosed. Nucleic acid-based genotyping assays using the oligonucleotides described herein as primers for amplification and / or sequencing are also disclosed.

BRPI0418722-9A 2004-04-07 2004-12-22 nucleic acid-based assays for identification of fc receptor polymorphisms BRPI0418722A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56064904P 2004-04-07 2004-04-07
PCT/US2004/043726 WO2005102379A2 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of fc receptor polymorphisms

Publications (1)

Publication Number Publication Date
BRPI0418722A true BRPI0418722A (en) 2007-09-11

Family

ID=35197498

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418722-9A BRPI0418722A (en) 2004-04-07 2004-12-22 nucleic acid-based assays for identification of fc receptor polymorphisms

Country Status (10)

Country Link
EP (1) EP1732939A4 (en)
JP (1) JP2007532110A (en)
KR (1) KR20070004082A (en)
CN (1) CN1976942A (en)
AU (1) AU2004318681A1 (en)
BR (1) BRPI0418722A (en)
CA (1) CA2562016A1 (en)
IL (1) IL178333A0 (en)
RU (1) RU2006138865A (en)
WO (1) WO2005102379A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181016A1 (en) * 2005-11-30 2009-07-16 University Of Southern California FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
EP2109686A2 (en) 2007-01-18 2009-10-21 University Of Southern California Genetic markers for predicting responsiveness to combination therapy
WO2009026502A1 (en) * 2007-08-22 2009-02-26 Wyeth Nested pcr-based method for specific genotyping of the fc-gamma receptor iiia gene
JP2016534749A (en) * 2013-10-15 2016-11-10 コネクシオ ゲノミクス ピーティーワイ リミテッド Major histocompatibility complex single nucleotide polymorphism
WO2021146521A1 (en) * 2020-01-16 2021-07-22 Acepodia Biotechnologies Ltd. A novel cd16+ natural killer cell and a method of culturing cd16+ natural killer cell
CN114277149B (en) * 2021-12-30 2023-09-22 苏州方科生物科技有限公司 Kit for detecting polymorphism of CD16A gene and application and use method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
AU2002346999B2 (en) * 2001-10-19 2007-11-08 Centre Hospitalier Regional Et Universitaire De Tours Methods and compositions to evaluate antibody treatment response

Also Published As

Publication number Publication date
JP2007532110A (en) 2007-11-15
EP1732939A2 (en) 2006-12-20
EP1732939A4 (en) 2008-09-17
CN1976942A (en) 2007-06-06
RU2006138865A (en) 2008-05-20
KR20070004082A (en) 2007-01-05
IL178333A0 (en) 2007-02-11
WO2005102379A2 (en) 2005-11-03
CA2562016A1 (en) 2005-11-03
AU2004318681A1 (en) 2005-11-03
WO2005102379A3 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
AU2017246663A1 (en) Multiplex nucleic acid assay methods capable of detecting closely related alleles, and reagents therefor
BRPI0513308A (en) systems and methods of analysis of nucleic acid polymers and related components
WO2007146819A3 (en) Methods for identifying and using snp panels
BRPI0607306A2 (en) quinoxaline derivatives as anti-tumor agents
CA3096478A1 (en) Highly selective nucleic acid amplification primers
CY1117260T1 (en) CHROMOSOME CONFORMATION CAPTURE-ON-CHIP TEST-UP-TO-CHOCOLATE TEST (4C)
WO2007041342A3 (en) Labeled nucleotide analogs and uses therefor
WO2015123430A3 (en) Single molecule electronic multiplex snp assay and pcr analysis
DK1721992T3 (en) Methods and nucleic acids for cellular proliferative disease assays
ATE542922T1 (en) 2'-TERMINATOR-ASSOCIATED PYROPHOSPHOROLYSIS-ACTIVATED POLYMERIZATION
DE60235005D1 (en) PROOF OF THE INSTABILITY OF MICROSATELLITES AND
ATE550441T1 (en) METHODS, COMPOSITIONS AND KITS FOR ISOTHERMAL AMPLIFICATION OF NUCLEIC ACIDS
WO2004023092A3 (en) Genetic analysis and authentication
WO2008088893A3 (en) Gene polymorphisms in vegf and vegf receptor 2 as markers for cancer therapy
BRPI0816047A2 (en) oligonucleotide array for detection of a target nucleic acid, methods for detecting the presence or absence of a target nucleic acid and at least two target nucleic acids, kit, reaction mixture and fluorescence-identified amplicon
WO2020132499A3 (en) Systems and methods for using fragment lengths as a predictor of cancer
DK1885882T3 (en) Methods for mapping polymorphisms and polymorphism microarray
PT1907588E (en) Assays for resistance to echinocandin-class drugs
BRPI0604761A (en) gene methylation detection
WO2007058968A3 (en) Gene expression profiles and methods of use
ATE507250T1 (en) SAMPLE LYSIS AND COATING OF A REACTION SURFACE
BRPI0418722A (en) nucleic acid-based assays for identification of fc receptor polymorphisms
WO2006039673A3 (en) Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles
WO2010099378A3 (en) Assay for detection of human parvovirus nucleic acid
WO2005112568A3 (en) Haplotype markers and methods of using the same to determine response to treatment

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US)

Free format text: ALTERADO DE: CHIRON CORPORATION

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.